Bruce Thornton - 29 Dec 2022 Form 4 Insider Report for Sonoma Pharmaceuticals, Inc. (SNOA)

Role
Chief Operating Officer
Signature
/s/ Amy Trombly as attorney-in-fact
Issuer symbol
SNOA
Transactions as of
29 Dec 2022
Net transactions value
$0
Form type
4
Filing time
30 Dec 2022, 16:01:33 UTC
Previous filing
14 Jan 2022
Next filing
03 Jul 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SNOA Stock option (right to buy) Award +40,000 +52% 116,781 29 Dec 2022 Common Stock 40,000 $1.08 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options vest one third each on 12/29/2023, 12/29/2024 and 12/29/2025, or upon change of control or as provided by Mr. Thornton's employment agreement.
F2 The options were awarded and granted to Mr. Thornton for services performed as part of the Company's annual grant of stock options.